Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article CME
  • Published:

The incidence, clinical features, and management of essential infantile esotropia in the United Kingdom. A British Ophthalmology Surveillance Unit (BOSU) study

Learning objectives

Upon completion of this activity, participants will be able to:

  1. 1.

    Distinguish the annual incidence of essential infantile esotropia (EIE) in the current study.

  2. 2.

    Assess the mean ages at diagnosis and intervention for EIE in the current study.

  3. 3.

    Compare characteristics of children who received observational management for EIE vs active interventions.

  4. 4.

    Evaluate outcomes of surgical treatment for EIE vs botulinum toxin in the current study.

Accreditation statements

In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Springer Nature. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit hours

1.0

Release date: February 2, 2024

Expiration date: February 2, 2025

Post-test link: https://www.medscape.org/eye/posttest999130

EDITOR

Sobha Sivaprasad, MD, Editor, Eye

Journal CME author disclosure information

Charles P. Vega has the following relevant financial relationships: Consultant or advisor for Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Johnson & Johnson Services, Inc.

Abstract

Background/objectives

A national study was undertaken through the British ophthalmology surveillance unit (BOSU) to determine the incidence, presenting features and management of essential infantile esotropia (EIE) in the UK.

Methods

Data from a prospective national observational study of newly diagnosed EIE presenting to clinicians in the United Kingdom over a 12-month period were collected. Cases with a confirmed diagnosis by a clinician of a constant, non-accommodative esotropia ≥20 prism dioptres (PD), presenting at ≤12 months, with no neurological or ocular abnormalities were identified through BOSU. Follow-up data were collected at 12 months.

Results

A total of 57 cases were reported giving an incidence of EIE of 1 in 12,828 live births. The mean age of diagnosis and intervention were 7.05 ± 2.6 months (range 2–12) and 14.7 ± 4.9 months (range 6.5–28.1), respectively. Management was surgical in 59.6%, botulinum toxin alone in 22.8%, and 17.5% were observed. The preoperative angle of esotropia was smaller in the observation group (P = 0.04). The postoperative angle of esotropia was not statistically significant between botulinum toxin or surgery (P = 0.3), although the age of intervention was earlier in the botulinum group (P = 0.007). Early intervention (before 12 months of age) did not influence the post-intervention motor outcomes between 0 and 10 prism dioptres of esotropia (P = 0.78).

Conclusions

The incidence of EIE in the UK is considerably lower than reported in other population-based studies. The preferred method of treatment was surgical with earlier intervention in those treated with botulinum toxin. An early age of intervention (<12 months) did not influence motor outcomes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Box plots of pre-intervention angle.
Fig. 2: Age of intervention.

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. This data will not be available past 2030.

References

  1. Louwagie CR, Diehl NN, Greenberg AE, Mohney BG. Is the incidence of infantile esotropia declining?: a population-based study from Olmsted County, Minnesota, 1965 to 1994. Arch Ophthalmol. 2009;127:200–3.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Arora A, Williams B, Arora AK, McNamara R, Yates J, Fielder A. Decreasing strabismus surgery. Br J Ophthalmol. 2005;89:409–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Carney CV, Lysons DA, Taplet JV. Is the incidence of constant esotropia in childhood reducing? Eye. 1995;9:40–1.

    PubMed  Google Scholar 

  4. Ferguson JA, Goldacre MJ, Henderson J, Bron AJ. Ophthalmology in the Oxford region: analysis of time trends from linked statistics. Eye (Lond). 1991;5:379–84.

    Article  PubMed  Google Scholar 

  5. MacEwen CJ, Chakrabarti HS. Why is squint surgery in children in decline? Br J Ophthalmol. 2004;88:509–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Finlay R. Unexpected beneficial effects of measles immunisation. Number of squint operations has decreased. BMJ. 2000;320:939.

    CAS  PubMed  Google Scholar 

  7. Heng SJ, MacEwen CJ. Decrease in the rate of esotropia surgery in the United Kingdom from 2000 to 2010. Br J Ophthalmol. 2013;97:598–600.

    Article  PubMed  Google Scholar 

  8. Lyons C. Surgery for infantile esotropia: how early is early? / Le traitement chirurgicale de l’esotropie infantile: «precoce», qu’est-ce a dire? Can J Ophthalmol. 2008;43:629.

    Article  PubMed  Google Scholar 

  9. Wong AM. Timing of surgery for infantile esotropia: sensory and motor outcomes. Can J Ophthalmol. 2008;43:643–51.

    Article  PubMed Central  PubMed  Google Scholar 

  10. McNeer KW, Tucker MG, Spencer RF. Botulinum toxin management of essential infantile esotropia in children. Arch Ophthalmol. 1997;115:1411–8.

    Article  CAS  PubMed  Google Scholar 

  11. Wright KW, Edelman PM, McVey JH, Terry AP, Lin M. High-grade stereo acuity after early surgery for congenital esotropia. Arch Ophthalmol. 1994;112:913–9.

    Article  CAS  PubMed  Google Scholar 

  12. Campos EC, Schiavi C, Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J Pediatr Ophthalmol Strabismus. 2000;37:328–32. quiz 54–5.

    Article  CAS  PubMed  Google Scholar 

  13. Simonsz HJ, Kolling GH, Unnebrink K. Final report of the early vs. late infantile strabismus surgery study (ELISSS), a controlled, prospective, multicenter study. Strabismus. 2005;13:169–99.

    Article  CAS  PubMed  Google Scholar 

  14. Mayet I, Ally N, Alli HD, Tikly M, Williams S. Botulinum neurotoxin injections in essential infantile esotropia-a comparative study with surgery in large-angle deviations. Eye (Lond). 2021;35:3071–6.

    Article  CAS  PubMed  Google Scholar 

  15. de Alba Campomanes AG, Binenbaum G, Campomanes Eguiarte G. Comparison of botulinum toxin with surgery as primary treatment for infantile esotropia. J AAPOS. 2010;14:111–6.

    Article  PubMed  Google Scholar 

  16. Birch E, Stager D, Wright K, Beck R. The natural history of infantile esotropia during the first six months of life. Pediatric Eye Disease Investigator Group. J AAPOS. 1998;2:325–8.

    Article  CAS  PubMed  Google Scholar 

  17. Pediatric Eye Disease Investigator Group, Christiansen SP, Chandler DL, Holmes JM, Arnold RW, Birch E, et al. Instability of ocular alignment in childhood esotropia. Ophthalmology. 2008;115:2266–74.

    Article  Google Scholar 

  18. Simonsz HJ, Kolling GH. Best age for surgery for infantile esotropia. Eur J Paediatr Neurol. 2011;15:205–8.

    Article  CAS  PubMed  Google Scholar 

  19. Birch EE, Stager DR Sr. Long-term motor and sensory outcomes after early surgery for infantile esotropia. J AAPOS. 2006;10:409–13.

    Article  PubMed  Google Scholar 

  20. Graham PA. Epidemiology of strabismus. Br J Ophthalmol. 1974;58:224–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Darlow BA, Clemett RS, Horwood LJ, Mogridge N. Prospective study of New Zealand infants with birth weight less than 1500 g and screened for retinopathy of prematurity: visual outcome at age 7-8 years. Br J Ophthalmol. 1997;81:935–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. VanderVeen DK, Allred EN, Wallace DK, Leviton A, Investigators ES. Strabismus at age 2 years in children born before 28 weeks’ gestation: antecedents and correlates. J Child Neurol. 2016;31:451–60.

    Article  PubMed  Google Scholar 

  23. Louwagie CR, Diehl NN, Greenberg AE, Mohney BG. Long-term follow-up of congenital esotropia in a population-based cohort. J AAPOS. 2009;13:8–12.

    Article  PubMed  Google Scholar 

  24. Fu VL, Stager DR, Birch EE. Progression of intermittent, small-angle, and variable esotropia in infancy. Invest Ophthalmol Vis Sci. 2007;48:661–4.

    Article  PubMed  Google Scholar 

  25. Pediatric Eye Disease Investigator Group. Spontaneous resolution of early-onset esotropia: experience of the Congenital Esotropia Observational Study. Am J Ophthalmol. 2002;133:109–18.

    Article  Google Scholar 

  26. Bhate M, Flaherty M, Martin FJ. Timing of surgery in essential infantile esotropia—what more do we know since the turn of the century? Indian J Ophthalmol. 2022;70:386–95.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Birch EE, Fawcett S, Stager DR. Why does early surgical alignment improve stereoacuity outcomes in infantile esotropia? J AAPOS. 2000;4:10–4.

    Article  CAS  PubMed  Google Scholar 

  28. O’Connor AR, Fawcett SI, Stager D. Factors influencing sensory outcome following surgical correction of infantile esotropia. Am Orthopt J. 2002;52:69–74.

    Article  PubMed  Google Scholar 

  29. Gerth C, Mirabella G, Li X, Wright T, Westall C, Colpa L, et al. Timing of surgery for infantile esotropia in humans: effects on cortical motion visual evoked responses. Invest Ophthalmol Vis Sci. 2008;49:3432–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Special thanks to Anwen Coughlan and Tina McDonald for their help with the data collection. Special thanks to the following for their participation in the BOSU study: Adam Bates, Anna Maino, Annegret Dahlmann-Noor, Anthony Quinn, Clare Roberts, Conrad Schmoll, Geeta Thurairajan, Gill Adams, I.Chris Lloyd, Jan Hoole, Jane Ashworth, Jeremy Butcher, Joanne Hancox, John Ferris, Kate Taylor, Lawrence Gnanaraj, Louise Allen, Lucy Barker, Luke Clifford, M.Ashwin Reddy, Manor Parulekar, Maria Theodorou, Maria Tsimpida, Peter Tiffin, Richard Bowman, Richard Smith, Robert Taylor, Rod Savides, Rosemary Lambley, Rosie Brennan, Stephanie West, Tamsin Sleep, Tina Duke, Vasileios Kostakis, Vernon Geh, Alan Mulvihill, Annie Joseph, Anthony Vivian, Aravind Reddy, Bina Parmar, Dinesh Dave, David Jones, G. A. Shun-Shin, James Acheson, Kate Bush, Michael Clarke, Shona Sutherland, Stephen Burgess, Susmito Biswas, Tina Duke, and Victoria Barrett.

Funding

The Paediatric Eye Fund at Cardiff and Vale University Health Board kindly funded a total of £5000.

Author information

Authors and Affiliations

Authors

Contributions

DCMY: research design, data collection, data analysis, manuscript preparation. RD: data collection. WJW: data analysis. PW: research concept, research design, data analysis, manuscript preparation.

Corresponding author

Correspondence to Patrick Watts.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yeo, D.C.M., Davies, R., Watkins, W.J. et al. The incidence, clinical features, and management of essential infantile esotropia in the United Kingdom. A British Ophthalmology Surveillance Unit (BOSU) study. Eye 38, 680–686 (2024). https://doi.org/10.1038/s41433-023-02901-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-023-02901-5

Search

Quick links